Hyperion Therapeutics Raises $60 Million Series C
...UTH SAN FRANCISCO, Calif., June 30 /PRNewswire/ -- hyperion Therapeutics, a privately held specialty pharmaceu...Aggarwal, M.D. of Panorama Capital have joined the hyperion Therapeutics Board of Directors. "Considerabl... Daniel Perez of Bay City Capital. "We believe the hyperion management team, with their extensive drug develop...Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis
...OUTH SAN FRANCISCO, Calif., June 2 /PRNewswire/ -- hyperion Therapeutics, Inc. today announced top-line result...formed from phenylacetic acid (PAA) and glutamine. hyperion has initiated a phase III clinical program for the...lets) per day has not been established. About hyperion Therapeutics ...Highland Capital Partners Expands Healthcare Team
...ssociate. He has specialized in early stage medical devices and biotechnology healthcare companies, and currently represents Highland on the boards of hyperion Therapeutics and OpGen. In addition, he is or has been actively involved in Highland's investments in BAROnova, Conor Medsystems, Magen BioSciences an...Hyperion Therapeutics Elects Lota Zoth to Board of Directors
...ractive opportunity. I look forward to helping the hyperion team continue to execute on its growth objectives....s Rivera, President and Chief Executive Officer of hyperion Therapeutics, Inc. "We look forward to her contrib...eye towards accessing the public markets." About hyperion Therapeutics ...William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
SOUTH SAN FRANCISCO, Calif., Jan. 7 /PRNewswire/ -- Hyperion Therapeutics, Inc., a privately-held biopharmaceutical company focused on the development and commercialization of hepatology and gastrointestinal therapies that address orphan and underserved patient populations with unmet medical n...Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
...TH SAN FRANCISCO, Calif., March 30 /PRNewswire/ -- hyperion Therapeutics, Inc. today announced top-line result...tion," said Don Santel, Chief Executive Officer of hyperion Therapeutics. "We are currently finalizing our ph... formed from phenylacetic acid and glutamine. hyperion and Ucyclyd Pharma, Inc., a subsidiary of Medicis ...Woods Hole Research Center plans controlled burn in Amazon rainforest
...ion satellites that are used to monitor active fires around the world. The fire and subsequent fire scar could both be easily seen, however, using the hyperion EO-1 sensor data. Our hope is that these studies will allow us to better monitor forest fire from space and, eventually, to determine which forests ar...Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert
...owered robot named Hyperion, also developed at Carnegie Mellon, was taken to the Atacama as a research test bed. Scientists conducted experiments with hyperion to determine the optimum design, software and instrumentation for a robot that would be used in more extensive experiments conducted in 2004 and in 20...Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
... financial capital provides a solid foundation for hyperion to fulfill its commitments and capitalize on the o...am Chris E. Rivera, President and CEO, co-founded hyperion Therapeutics in 2006, and led the execution of the...e President Global Strategy and Operations, joined hyperion Therapeutics from Ucyclyd Pharma, Inc, a subsidiar...Hyperion Therapeutics Secures $40 Million In Series B Round
... "We are pleased with the investors' confidence in hyperion and our team," said Chris Rivera, President and CE... "We are excited about the attention and focus the hyperion team will bring to increasing UCD diagnosis and im...ns. We look forward to working in partnership with hyperion on shared goals to improve the lives of UCD patien...